<!doctype html>
<html lang="es">
<head>
<meta charset="utf-8" />
<meta name="viewport" content="width=device-width, initial-scale=1" />
<title>Spanish Daily – Dec 13, 2025</title>
<meta name="color-scheme" content="light" />
<style>
  :root { --maxw: 800px; color-scheme: light; }
  html { -webkit-text-size-adjust: 100%; }
  body {
    margin: 0;
    padding: 0;
    background-color: #ffffff;
    color: #111111;
    font-family: system-ui,-apple-system,Segoe UI,Roboto,Helvetica,Arial,sans-serif,Apple Color Emoji,Segoe UI Emoji;
    line-height: 1.6;
    font-size: 18px;
  }
  header, main, footer { max-width: var(--maxw); margin: 0 auto; padding: 16px; }
  header { padding-top: 20px; }
  h1 { font-size: 1.4rem; margin: 0 0 8px; }
  .subtle { opacity: 0.72; font-size: 0.95rem; }
  .card { border: 1px solid rgba(0,0,0,0.08); border-radius: 12px; padding: 14px; margin: 12px 0; }
  .tip-word { all: unset; display: inline; position: relative; cursor: pointer;
    text-decoration: underline dotted; text-underline-offset: 3px;
    padding: 0 .1em; border-radius: .35em; background: rgba(255,235,59,.28); }
  .tooltip { position: fixed; padding: .48rem .6rem; background: rgba(0,0,0,.88); color: #fff;
    border-radius: .55rem; font-size: .95rem; line-height: 1.3; max-width: min(90vw, 26rem);
    z-index: 9999; box-shadow: 0 6px 18px rgba(0,0,0,.18); }
  .content { white-space: pre-line; }
  .card { margin-bottom: 1.5em; line-height: 1.6; }
  strong { display: inline-block; margin-top: .35em; }
  details { border: 1px solid rgba(0,0,0,0.08); border-radius: 12px; padding: 12px; }
  details + details, details + .card { margin-top: 12px; }
  summary { cursor: pointer; font-weight: 600; }
  summary::marker { content: ""; }
  summary::after { content: " ▸"; }
  details[open] summary::after { content: " ▾"; }
  .debug { position: fixed; bottom: 8px; right: 8px; font-size: 12px; opacity: .6; }
</style>
</head>
<body>
  <header>
    <h1>Spanish Daily</h1>
    <div class="subtle">Toca una palabra subrayada para ver la traducción. Toca fuera para cerrar.</div>
  </header>

  <main>
    <!-- Spanish first -->
    <section class="card content">
STORY

La <span title="renal denervation">denervación renal</span> (DRN) <span title="is again">vuelve a ser</span> un <span title="possible additional treatment">posible tratamiento adicional</span> para la <span title="resistant hypertension">hipertensión resistente</span>. <span title="New controlled studies">Nuevos estudios controlados</span> <span title="with simulation">con simulación</span> <span title="correct problems">corrigen problemas</span> de <span title="previous negative studies">estudios negativos previos</span>. Ahora <span title="DRN is also being studied">también se estudia la DRN</span> en la <span title="chronic kidney disease">enfermedad renal crónica</span> (ERC). En la ERC, el <span title="strict control">control estricto</span> de la <span title="blood pressure">presión arterial</span> (PA) y la <span title="sympathetic modulation">modulación simpática</span> <span title="can modify">pueden modificar</span> el <span title="cardiovascular and renal risk">riesgo cardiovascular y renal</span>. Pero <span title="we still do not have">aún no tenemos</span> <span title="solid outcome data">datos sólidos de desenlaces</span>.

<span title="Recent DRN trials">Ensayos recientes de DRN</span> <span title="with catheter and sham control">con catéter y control simulador</span>, como SPYRAL HTN‑ON MED, SPYRAL HTN‑OFF MED y RADIANCE‑HTN, <span title="show that">muestran que</span> la PA <span title="in office and ambulatory">en consultorio y ambulatoria</span> <span title="drops between">baja entre</span> 5 y 10 mmHg <span title="more than with simulation">más que con simulación</span>. <span title="This effect lasts">Este efecto dura</span> <span title="at least">al menos</span> 2–3 años. <span title="No major safety problems have been reported">No se han reportado grandes problemas de seguridad</span>.

<span title="New ultrasound and radiofrequency systems">Nuevos sistemas de ultrasonido y radiofrecuencia</span> <span title="perform circumferential ablation">realizan ablación circunferencial</span> de las <span title="main renal arteries">arterias renales principales</span> y sus ramas. Las <span title="vascular complications">complicaciones vasculares</span> <span title="are rare">son raras</span>. La <span title="drop in eGFR">caída del eGFR</span> <span title="is not worse than">no es peor que</span> en los controles.

<span title="Post hoc analyses">Análisis post hoc</span> y <span title="small groups">pequeños grupos</span> <span title="with CKD and eGFR">con ERC y eGFR</span> de aproximadamente 30–60 mL/min/1.73 m² <span title="show a reduction">muestran una reducción</span> de PA <span title="similar to">similar a</span> la de <span title="patients without CKD">pacientes sin ERC</span>. <span title="There is no clear evidence">No hay evidencia clara</span> de una <span title="faster loss of eGFR">pérdida más rápida de eGFR</span> ni de <span title="renal artery stenosis">estenosis de la arteria renal</span>, pero los <span title="numbers are small">números son pequeños</span> y el <span title="follow-up is short">seguimiento es corto</span>.

La <span title="sympathetic modulation">modulación simpática</span> <span title="could help with">podría ayudar con</span> la <span title="albuminuria and nighttime BP">albuminuria y la PA nocturna</span>. <span title="Initial data show">Datos iniciales muestran</span> <span title="lower albumin excretion">menor excreción de albúmina</span> y <span title="better nighttime dipping pattern">mejor patrón de descenso nocturno</span>, pero los <span title="studies are too small">estudios son demasiado pequeños</span> <span title="for hard renal outcomes">para desenlaces renales duros</span>.

La <span title="regulatory approval">aprobación regulatoria</span> en EE. UU. y la UE <span title="for some patients">para algunos pacientes</span> <span title="with uncontrolled or resistant hypertension">con hipertensión no controlada o resistente</span> <span title="is starting">está iniciando</span> <span title="new interventional programs">nuevos programas intervencionistas</span>. <span title="There are ongoing trials">Hay ensayos en curso</span> en ERC, <span title="transplant hypertension">hipertensión en trasplante</span> y <span title="heart failure">falla cardíaca</span>.

<span title="For practice">Para la práctica</span>: la DRN <span title="is a real option">es una opción real</span> <span title="device-based">basada en dispositivos</span> para la <span title="truly resistant hypertension">hipertensión verdaderamente resistente</span>, <span title="even in some patients">incluso en algunos pacientes</span> con ERC. <span title="It is better in">Es mejor en</span> <span title="joint nephrology and cardiology programs">programas conjuntos de nefrología y cardiología</span> que <span title="can interpret">puedan interpretar</span> <span title="new outcome data">nuevos datos de desenlaces</span> y <span title="offer personalized counseling">ofrecer asesoría personalizada</span> de <span title="risks and benefits">riesgos y beneficios</span>.

---
DIALOGUE

Narrator: <span title="Let's talk about">Vamos a hablar de</span> un <span title="new treatment">nuevo tratamiento</span> para la <span title="high blood pressure">presión arterial alta</span> llamado <span title="renal denervation">denervación renal</span>.
Physician: Su <span title="blood pressure">presión arterial</span> <span title="remains high">sigue alta</span>, <span title="even with">incluso con</span> <span title="many medications">muchos medicamentos</span>.
Patient: Sí, <span title="my numbers do not go down">mis cifras no bajan</span>. <span title="I feel worried">Me siento preocupado</span>.
Physician: <span title="There is an option">Existe una opción</span> llamada <span title="renal denervation">denervación renal</span>. <span title="It is a device treatment">Es un tratamiento con dispositivo</span>, <span title="not a pill">no una pastilla</span>.
Patient: <span title="How does this work">¿Cómo funciona esto</span>?
Physician: <span title="We use a special catheter">Usamos un catéter especial</span> <span title="to treat the nerves">para tratar los nervios</span> en las <span title="arteries of your kidneys">arterias de sus riñones</span>. <span title="This can lower">Esto puede bajar</span> la <span title="blood pressure">presión arterial</span>.
Patient: <span title="Is it safe">¿Es seguro</span>? <span title="Will it damage my kidneys">¿Dañará mis riñones</span>?
Physician: <span title="New studies show">Nuevos estudios muestran</span> que <span title="it is safe">es seguro</span>. La <span title="kidney function">función renal</span> <span title="does not get worse">no empeora</span>. Los <span title="problems are very rare">problemas son muy raros</span>.
Patient: <span title="Will my blood pressure drop a lot">¿Mi presión bajará mucho</span>?
Physician: <span title="It can lower your pressure">Puede bajar su presión</span> <span title="between five and ten">entre cinco y diez</span> <span title="millimeters of mercury">milímetros de mercurio</span>.
Patient: <span title="Should I stop my other medications">¿Debo dejar mis otros medicamentos</span>?
Physician: <span title="Most people keep taking medications">La mayoría de las personas sigue tomando medicamentos</span>, pero <span title="sometimes we can lower the dose">a veces podemos bajar la dosis</span>.
Patient: <span title="What happens after the procedure">¿Qué pasa después del procedimiento</span>?
Physician: <span title="We monitor your blood pressure">Vigilamos su presión arterial</span> y los <span title="kidney tests">exámenes de riñón</span> <span title="frequently">con frecuencia</span>. <span title="You will see">Usted verá</span> tanto a <span title="my team">mi equipo</span> como al <span title="nephrologist">nefrólogo</span>.
    </section>

    <!-- English below -->

    <details open class="card content">
      <summary>INGLÉS</summary>
STORY

Renal denervation (RDN) is again a possible extra treatment for resistant hypertension. New sham‑controlled trials fix problems from older negative studies. Now people also look at RDN in chronic kidney disease (CKD). In CKD, tight blood pressure (BP) control and sympathetic modulation may change cardiovascular and renal risk. But we do not yet have strong outcome data.

Recent sham‑controlled catheter‑based RDN trials like SPYRAL HTN‑ON MED, SPYRAL HTN‑OFF MED, and RADIANCE‑HTN show office and ambulatory BP goes down about 5–10 mmHg more than sham. This lasts at least 2–3 years. There are no big safety problems.

New ultrasound and radiofrequency systems do circumferential ablation of main and branch renal arteries. Vascular complications are rare. eGFR drop is not worse than in controls.

Post‑hoc and small CKD groups with eGFR about 30–60 mL/min/1.73 m² show BP fall like in non‑CKD. There is no clear faster eGFR loss or renal artery stenosis, but numbers are small and follow‑up is short.

Sympathetic modulation may help albuminuria and nocturnal BP. Early data show less albumin excretion and better dipping status, but studies are too small for hard renal outcomes.

Regulatory approval in the US and EU for some patients with uncontrolled or resistant hypertension is starting new interventional programs. Trials in CKD, transplant hypertension, and heart failure are running.

For practice: RDN is a real device‑based choice for truly resistant hypertension, even in some CKD patients. It is best in joint nephrology–cardiology programs that can read new outcome data and give personal risk–benefit talks.

---
DIALOGUE

Narrator: We will talk about a new treatment for high blood pressure called renal denervation.
Physician: Your blood pressure is still high, even with many medicines.
Patient: Yes, my numbers do not go down. I feel worried.
Physician: There is a way called renal denervation. It is a device treatment, not a pill.
Patient: How does this work?
Physician: We use a special catheter to treat the nerves in your kidney arteries. This can lower blood pressure.
Patient: Is it safe? Will it hurt my kidneys?
Physician: New studies show it is safe. Kidney function does not get worse. Problems are very rare.
Patient: Will my blood pressure go much lower?
Physician: It can lower your pressure by around five to ten millimeters of mercury.
Patient: Do I need to stop my other medicines?
Physician: Most people keep taking medicine, but sometimes we can lower the dose.
Patient: What happens after the procedure?
Physician: We watch your blood pressure and kidney tests often. You will see both my team and the kidney doctor.
    </details>
  </main>

  <footer class="subtle">
    <div>© Dec 13, 2025 · Mezra.AI · Practica todos los días.</div>
  </footer>

  <div class="debug">EN: found</div>

  <!-- NEW: light cache-busting helper -->
  <script>
  (function() {
    // 1. Get the version tag from the URL, if present (?v=SHA...)
    var params = new URLSearchParams(window.location.search);
    var version = params.get('v');

    // 2. Read the debug indicator already inside your page
    var debug = document.querySelector('.debug');
    var debugText = debug ? debug.textContent.trim() : '';

    // 3. Heuristic: if version is missing or debug looks suspicious, force a one-time reload
    var isLikelyStale =
      !version ||
      debugText === '' ||
      debugText.indexOf('placeholder') !== -1 ||
      debugText.indexOf('not found') !== -1 ||
      debugText.length < 3;

    if (isLikelyStale) {
      if (!params.get('forceReload')) {
        params.set('forceReload', '1');
        var newUrl = window.location.pathname + '?' + params.toString();
        window.location.replace(newUrl);
      }
    }
  })();
  </script>

  <!-- Existing tooltip behavior -->
  <script>
  (function () {
    document.querySelectorAll('.content').forEach(function(container) {
      container.querySelectorAll('span[title]').forEach(function(span) {
        var text = span.textContent;
        var tip  = span.getAttribute('title');
        var btn  = document.createElement('button');
        btn.className = 'tip-word'; btn.type = 'button';
        btn.textContent = text; btn.setAttribute('data-tip', tip);
        span.replaceWith(btn);
      });
    });

    var openTip = null;
    function closeTip(){ if(openTip){ openTip.remove(); openTip = null; } }
    function showTip(target){
      closeTip();
      var tipText = target.getAttribute('data-tip') || '';
      if(!tipText) return;
      var bubble = document.createElement('div');
      bubble.className = 'tooltip';
      bubble.textContent = tipText;
      document.body.appendChild(bubble);
      var r = target.getBoundingClientRect();
      var m = 8, vw = innerWidth, vh = innerHeight;
      var rect = bubble.getBoundingClientRect();
      var tw = rect.width;
      var th = rect.height;
      var left = r.left, top = r.bottom + m;
      if (left + tw + m > vw) left = Math.max(m, vw - tw - m);
      if (left < m) left = m;
      if (top + th + m > vh) top = Math.max(m, r.top - th - m);
      bubble.style.left = left + 'px';
      bubble.style.top  = top + 'px';
      openTip = bubble;
    }

    document.addEventListener('click', function(e) {
      var word = e.target.closest('.tip-word');
      if (word){ if (openTip) closeTip(); else showTip(word); e.stopPropagation(); }
      else { closeTip(); }
    });
    document.addEventListener('touchstart', function(e) {
      if (!e.target.closest('.tip-word')) closeTip();
    }, { passive: true });
    addEventListener('scroll', closeTip, { passive: true });
    addEventListener('resize', closeTip);
    document.addEventListener('keydown', function(e) { if (e.key === 'Escape') closeTip(); });
  })();
  </script>
</body>
</html>